Summary:
Cellerix is a biotechnology company actively developing and producing innovative medicines based on the use of stem cells of adult origin. The company is engaged in clinical trials for the treatment of fistulas and skin regeneration.
Visit Cellerix.

Description (Web site quote):
Cellerix is a biotechnology company actively developing and producing innovative medicines based on the use of stem cells of adult origin. The company is engaged in clinical PhaseII trials for the treatment of complex perianal fistulas.

Since its foundation in 2004 as part of Genetrix Group, Cellerix is a Cell Therapy Company with a sharp clinical focus. The company maintains a solid product pipeline, targeting main indications for fistula treatment and skin regeneration (Cx 501). One of Cellerix products (Cx 401) has reached Orphan Drug Status granted by EMEA and is currently in Phase II clinical stage.

Cellerix has strong expertise in clinical trials and regulatory issues related to Cell Therapy. The company has developed the only laboratory in Spain granted by the AEMPS for the production of cellular medicines.
Visit Cellerix.